Cargando…
Response to trabectedin in a patient with advanced synovial sarcoma with lung metastases
Trabectedin is an alkylating agent registered in Europe for the treatment of advanced metastatic soft-tissue sarcomas, whose activity has been documented mainly in liposarcomas or leiomyosarcomas. Here, we report the response achieved in a patient with lung metastases from synovial sarcoma. A man wi...
Autores principales: | Zanardi, Elisa, Maruzzo, Marco, Montesco, Maria C., Roma, Anna, Rastrelli, Marco, Basso, Umberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222791/ https://www.ncbi.nlm.nih.gov/pubmed/25075796 http://dx.doi.org/10.1097/CAD.0000000000000158 |
Ejemplares similares
-
Long-term response to first-line trabectedin in an elderly female patient with a metastatic leiomyosarcoma unfit for anthracycline
por: Maruzzo, Marco, et al.
Publicado: (2016) -
Trabectedin Drug Holiday and Rechallenge in Soft Tissue Sarcomas: Report of 4 Cases and Literature Review
por: Pierantoni, Francesco, et al.
Publicado: (2019) -
Neoadjuvant sirolimus for a large hepatic perivascular epithelioid cell tumor (PEComa)
por: Bergamo, Francesca, et al.
Publicado: (2014) -
Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience
por: Brunello, Antonella, et al.
Publicado: (2015) -
Trabectedin: Safety and Efficacy in the Treatment of Advanced Sarcoma
por: Gajdos, Csaba, et al.
Publicado: (2011)